The role of coinfection with influenza viruses in the pathogenesis of severe infection in patients with COVID-19

Abstract

BACKGROUND: Despite the continuing global spread of the coronavirus infection COVID-19 caused by the SARS-CoV-2 coronavirus, the mechanisms of the pathogenesis of severe infections remain poorly understood. The role of comorbidity with other seasonal viral infections, including influenza, in the pathogenesis of the severe course of COVID-19 remains unclear.

MATERIALS AND METHODS: The present study used sera left over from ongoing laboratory studies of patients with varying degrees of severity of COVID-19. The study was approved by the Local Ethics Committee of the Federal State Budgetary Scientific Institution “IEM” (protocol 3/20 from 06/05/2020). We studied 28 paired samples obtained upon admission of patients to the hospital and after 5–7 days of hospital stay. Paired sera of patients with COVID-19 were tested for antibodies to influenza A and B viruses. The presence of IgG antibodies specific to the SARS-CoV-2 spike (S) protein was studied using an enzyme-linked immunosorbent assay (ELISA). The serum concentration of C-reactive protein and the neutrophil-lymphocyte ratio on the day of hospitalization were also assessed.

RESULTS: At least a 4-fold increase in serum IgG antibodies to SARS-CoV-2 S protein was found both in patients with PCR-confirmed SARS-CoV-2 infection and without PCR confirmation. It was shown that out of 18 patients with moderate and severe forms of COVID-19 infection, six of them showed at least a 4-fold increase in antibodies to influenza A/H1N1, in one to influenza A/H3N2 and in two cases to the influenza B. Laboratory data in these two groups were characterized by significant increases in serum C-reactive protein and neutrophil-lymphocyte ratio concentrations compared with the moderate COVID-19 group.

CONCLUSIONS: Serological diagnostics can additionally detect cases of coronavirus infection when the virus was not detected by PCR. In moderate and severe cases of COVID-19, coinfections with influenza A and B viruses have been identified. The results obtained confirm the need for anti-influenza immunization during the SARS-CoV-2 pandemic. Influenza virus screening can significantly improve patient management because recommended antiviral drugs (neuraminidase inhibitors) are available.

Keywords

coronavirus infection / influenza viruses / serodiagnostics / coinfection

References

[1] Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. DOI: 10.1038/s41579-020-00459-7

[2] Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19 // Nat. Rev. Microbiol. 2021. Vol. 19, No. 3. P. 141–154. DOI: 10.1038/s41579-020-00459-7

[3] Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26(6):1324–1326. DOI: 10.3201/eid2606.200299

[4] Wu X., Cai Y., Huang X. et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China // Emerg. Infect. Dis. 2020. Vol. 26, No. 6. P. 1324–1326. DOI: 10.3201/eid2606.200299

[5] Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, et al. SARS-CoV-2 and influenza virus co-infection. Lancet. 2020;395(10236):e84. DOI: 10.1016/S0140-6736(20)31052-7

[6] Cuadrado-Payán E., Montagud-Marrahi E., Torres-Elorza M. et al. SARS-CoV-2 and influenza virus co-infection // Lancet. 2020. Vol. 395, No. 10236. P. e84. DOI: 10.1016/S0140-6736(20)31052-7

[7] Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–256. DOI: 10.1002/jmv.26232

[8] Hu B., Huang S., Yin L. The cytokine storm and COVID-19 // J. Med. Virol. 2021. Vol. 93, No. 1. P. 250–256. DOI: 10.1002/jmv.26232

[9] Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020;180(7):934–943. DOI: 10.1001/jamainternmed.2020.0994

[10] Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China // JAMA Int. Med. 2020. Vol. 180, No. 7. P. 934–943. DOI: 10.1001/jamainternmed.2020.0994

[11] Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999;37(4):937–943. DOI: 10.1128/JCM.37.4.937-943.1999

[12] Rowe T., Abernathy R.A., Hu-Primmer J. et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays // J. Clin. Microbiol. 1999. Vol. 37, No. 4. P. 937–943. DOI: 10.1128/JCM.37.4.937-943.1999

[13] Yue H, Zhang M, Xing L, et al. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak. J Med Virol. 2020;92(11):2870–2873. DOI: 10.1002/jmv.26163.

[14] Yue H., Zhang M., Xing L. et al. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak // J. Med. Virol. 2020. Vol. 92, No. 11. P. 2870–2873. DOI: 10.1002/jmv.26163

[15] Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31(4):395–403. DOI: 10.1038/s41422-021-00473-1

[16] Bai L., Zhao Y., Dong J. et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity // Cell. Res. 2021. Vol. 31, No. 4. P. 395–403. DOI: 10.1038/s41422-021-00473-1

[17] Stringer D, Braude P, Myint PK, et al. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021;50(2):420–429. DOI: 10.1093/ije/dyab012

[18] Stringer D., Braude P., Myint P.K. et al. The role of C-reactive protein as a prognostic marker in COVID-19 // Int. J. Epidemiol. 2021. Vol. 50, No. 2. P. 420–429. DOI: 10.1093/ije/dyab012

[19] Kulkarni A, Divya Prabhu, Likitesh AB, et al. Utility of neutrophil-lymphocyte ratio (NLR) as an indicator of disease severity and prognostic marker among patients with COVID-19 infection in a tertiary care centre in Bangalore – a retrospective study. Journal of Evidence Based Medicine and Healthcare. 2021;8(16):1020–1024. DOI: 10.18410/jebmh/2021/197

[20] Kulkarni A., Divya Prabhu, Likitesh A.B. et al. Utility of neutrophil-lymphocyte ratio (NLR) as an indicator of disease severity and prognostic marker among patients with COVID-19 infection in a tertiary care center in Bangalore – a retrospective study // Journal of Evidence Based Medicine and Healthcare. 2021. Vol. 8, No. 16. P. 1020–1024. DOI: 10.18410/jebmh/2021/197

RIGHTS & PERMISSIONS

Shvedova T.N., Kopteva O.S., Kudar P.A., Lerner A.A., Desheva Y.A.